While the current study provides valuable insights into the potential of GPF in AD treatment, we acknowledge that more advanced AD animal models, such as APP/PS1 mice and 3 ​× ​AD mice, would offer a more robust platform for exploring the effects and mechanisms of our compounds [34,56]. The gene discussed is APP; the disease is Alzheimer disease.